Literature DB >> 28090403

A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome.

Bory Kea1, Tahroma Alligood2, Vincent Manning3, Merritt Raitt4.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia encountered by clinicians. Clinical decision-making focuses on reducing ischemic stroke risk in AF patients; however, AF is also associated with an increased risk of acute coronary syndromes (ACS). Patients with ACS and concurrent AF are less likely to receive appropriate therapies and more likely to experience adverse outcomes than ACS patients in sinus rhythm (SR). Clinicians may be able to stratify ACS patients at increased risk of AF development based on clinical characteristics. Evidence supporting specific therapeutic options for prevention of ACS in AF patients or for prevention of AF in ACS patients is limited, however there is some evidence of differing effects among oral anticoagulant regimens in these populations. Investigations of the relationship of AF with the full spectrum of ACS are not well described and should be the focus of future research.

Entities:  

Keywords:  Acute Coronary Syndrome; Atrial Fibrillation; Clinical Decision-Making; Myocardial Infarction; Sinus Rhythm; Unstable Angina

Year:  2016        PMID: 28090403      PMCID: PMC5232421          DOI: 10.1007/s40138-016-0105-2

Source DB:  PubMed          Journal:  Curr Emerg Hosp Med Rep        ISSN: 2167-4884


  94 in total

1.  An uncommon cause of myocardial infarction.

Authors:  Govind Srinivasan; Seif El-Jack; Colin Edwards; Guy P Armstrong; Hamish Hart; Jonathan P Christiansen
Journal:  Heart Lung Circ       Date:  2011-03       Impact factor: 2.975

2.  Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction.

Authors:  Tohru Yoshizaki; Ken Umetani; Yuri Ino; Souichirou Takahashi; Masahiko Nakamura; Toshikuni Seto; Kazunori Aizawa
Journal:  Intern Med       Date:  2012-06-15       Impact factor: 1.271

3.  Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study.

Authors:  C Martinez; A Katholing; S B Freedman
Journal:  Thromb Haemost       Date:  2014-06-18       Impact factor: 5.249

4.  New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients--a Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy.

Authors:  Anne-Christine Huth Ruwald; Poul Erik Bloch Thomsen; Uffe Gang; Rikke Mørch Jørgensen; Heikki V Huikuri; Christian Jons
Journal:  Am Heart J       Date:  2013-09-26       Impact factor: 4.749

Review 5.  Stroke prevention in atrial fibrillation: a systematic review.

Authors:  Gregory Y H Lip; Deirdre A Lane
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

6.  Atrial fibrillation in Middle Eastern Arab and South Asian patients hospitalized with acute myocardial infarction: experience from a 20-year registry in qatar (1991-2010).

Authors:  Amar M Salam; Binali Hajar A Al; Rajvir Singh; Abdurrazzak Gehani; Nidal Asaad; Awad Al-Qahtani; Jassim Al Suwaidi
Journal:  Acta Cardiol       Date:  2013-04       Impact factor: 1.718

7.  Clinical utility and prognostic significance of measuring troponin I levels in patients presenting to the emergency room with atrial fibrillation.

Authors:  Kamal Gupta; Jayasree Pillarisetti; Mazda Biria; Micah Pescetto; Tareq M Abu-Salah; Chandra Annapureddy; Kay Ryschon; Buddhadeb Dawn; Dhanunjaya Lakkireddy
Journal:  Clin Cardiol       Date:  2014-04-02       Impact factor: 2.882

8.  Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.

Authors:  Winnie W Nelson; Li Wang; Onur Baser; Chandrasekharrao V Damaraju; Jeffrey R Schein
Journal:  Int J Clin Pharm       Date:  2014-11-27

9.  New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.

Authors:  Casper N Bang; Gunnar H Gislason; Anders M Greve; Christian A Bang; Alexander Lilja; Christian Torp-Pedersen; Per K Andersen; Lars Køber; Richard B Devereux; Kristian Wachtell
Journal:  J Am Heart Assoc       Date:  2014-01-21       Impact factor: 5.501

10.  Blood count in new onset atrial fibrillation after acute myocardial infarction - a hypothesis generating study.

Authors:  Klaus Distelmaier; Gerald Maurer; Georg Goliasch
Journal:  Indian J Med Res       Date:  2014-04       Impact factor: 2.375

View more
  5 in total

Review 1.  Toxic alcohol diagnosis and management: an emergency medicine review.

Authors:  Patrick Chow Yuen Ng; Brit J Long; William Tyler Davis; Daniel J Sessions; Alex Koyfman
Journal:  Intern Emerg Med       Date:  2018-02-09       Impact factor: 3.397

Review 2.  Clinical chameleons: an emergency medicine focused review of carbon monoxide poisoning.

Authors:  Patrick Chow Ng; Brit Long; Alex Koyfman
Journal:  Intern Emerg Med       Date:  2018-02-12       Impact factor: 3.397

3.  Predictors of Acute Atrial Fibrillation and Flutter Hospitalization across 7 U.S. Emergency Departments: A Prospective Study.

Authors:  Bory Kea; E Margaret Warton; Dustin W Ballard; Dustin G Mark; Mary E Reed; Adina S Rauchwerger; Steven R Offerman; Uli K Chettipally; Patricia C Ramos; Daphne D Le; David S Glaser; David R Vinson
Journal:  J Atr Fibrillation       Date:  2021-02-28

4.  Practice Gap in Atrial Fibrillation Oral Anticoagulation Prescribing at Emergency Department Home Discharge.

Authors:  Bory Kea; Bethany T Waites; Amber Lin; Merritt Raitt; David R Vinson; Niroj Ari; Luke Welle; Andrew Sill; Dana Button; Benjamin C Sun
Journal:  West J Emerg Med       Date:  2020-06-29

5.  Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.

Authors:  Simone Rivolo; Manuela Di Fusco; Carlos Polanco; Amiee Kang; Devender Dhanda; Mirko Savone; Aristeidis Skandamis; Thitima Kongnakorn; Javier Soto
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.